We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SNSE market cap is 12.08M. The company's latest EPS is USD -1.3558 and P/E is -0.36.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.74M | -8.14M | -8.73M | -7.79M | -7.82M |
| Net Income | -7.12M | -7.41M | -7.99M | -7.14M | -7.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.44M | -19.45M | -37.48M | -50.19M | -37.06M |
| Net Income | -20.54M | -20.2M | -36.79M | -48.59M | -34.1M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 81.66M | 74.37M | 66.7M | 59.8M | 53.25M |
| Total Liabilities | 10.66M | 9.48M | 8.22M | 7.61M | 7.48M |
| Total Equity | 71M | 64.9M | 58.47M | 52.19M | 45.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.22M | 21.43M | 153.23M | 118.38M | 74.37M |
| Total Liabilities | 22.33M | 5.54M | 6.71M | 14.97M | 9.48M |
| Total Equity | -68.66M | -56.44M | 146.51M | 103.41M | 64.9M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.86M | -32.02M | -7.62M | -13.41M | -18.88M |
| Investing | 30.15M | 38.41M | 5.77M | 12.68M | 25.59M |
| Financing | -10.74M | -11.17M | -209k | -389k | -593k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.57M | -17.71M | -30.26M | -39.03M | -32.02M |
| Investing | -53k | -1.4M | -143.12M | 49.95M | 38.41M |
| Financing | 8.22M | 35.45M | 163.94M | -287k | -11.17M |
| Market Cap | 12.08M |
| Price to Earnings Ratio | -0.36 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.95 |
| Price to Book Ratio | 0.19 |
| Dividend Yield | - |
| Shares Outstanding | 25.15M |
| Average Volume (1 week) | 195.28k |
| Average Volume (1 Month) | 233.08k |
| 52 Week Change | -33.32% |
| 52 Week High | 1.94 |
| 52 Week Low | 0.384 |
| Spread (Intraday) | 0.02 (3.03%) |
| Company Name | Sensei Biotherapeutics Inc |
| Address |
800 north state street dover, delaware 19901 |
| Website | https://www.senseibio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
